Calendar

Financial Releases

Date Title  
Toggle Summary AbbVie to Host Third-Quarter 2019 Earnings Conference Call
  NORTH CHICAGO, Ill. , Oct. 8, 2019 /PRNewswire/ --   AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will announce its third-quarter 2019 financial results on Friday, November 1 before the market opens. AbbVie will host a live webcast of the earnings conference call at 8
Toggle Summary AbbVie Declares Quarterly Dividend
NORTH CHICAGO, Ill. , Sept. 6, 2019 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $1.07 per share.  The cash dividend is payable November 15, 2019 to stockholders of record at the close of business on October 15, 2019 .
Toggle Summary AbbVie to Present at the Morgan Stanley Healthcare Conference
NORTH CHICAGO, Ill. , Aug. 27, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the Morgan Stanley 17 th Annual Global Healthcare Conference on Tuesday, September 10 , 2019.  Richard A. Gonzalez , chairman and chief executive officer,
Toggle Summary AbbVie Reports Second-Quarter 2019 Financial Results
- Announced a Definitive Transaction Agreement to Acquire Allergan, Significantly Expanding and Diversifying AbbVie's Revenue Base with New Therapeutic Areas and Enhancing Long-Term R&D Funding Capacity to Allow for Continued Investment in Innovative Science - Reports Second-Quarter Diluted EPS of
Toggle Summary AbbVie to Host Second-Quarter 2019 Earnings Conference Call
NORTH CHICAGO, Ill. , July 11, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will announce its second-quarter 2019 financial results on Friday, July 26 before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m.
Toggle Summary AbbVie to Acquire Allergan in Transformative Move for Both Companies
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION THIS ANNOUNCEMENT IS BEING MADE PURSUANT TO RULE 2.5 OF THE IRISH TAKEOVER RULES - Provides
Toggle Summary AbbVie Declares Quarterly Dividend
NORTH CHICAGO, Ill. , June 20, 2019 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $1.07 per share.  The cash dividend is payable August 15, 2019 to stockholders of record at the close of business on July 15, 2019 .
Toggle Summary AbbVie to Present at the Goldman Sachs Global Healthcare Conference
NORTH CHICAGO, Ill. , June 7, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the Goldman Sachs 40 th Annual Global Healthcare Conference on Wednesday, June 12, 2019 . Michael Severino , vice chairman and president, will present at
Toggle Summary AbbVie to Present at the UBS Global Healthcare Conference
NORTH CHICAGO, Ill. , May 14, 2019 /PRNewswire/ --  AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the UBS Global Healthcare Conference on Tuesday, May 21, 2019 . Michael Severino , vice chairman and president, will present at 7:30 a.m. Central time .
Toggle Summary AbbVie to Present at the Bank of America Merrill Lynch Healthcare Conference
NORTH CHICAGO, Ill. , May 7, 2019 /PRNewswire/ --  AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the Bank of America Merrill Lynch Healthcare Conference on Wednesday, May 15, 2019 . Michael Severino , vice chairman and president, will present at 3:00